reference/19457150

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/19457150

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Clinical Trial, Phase II\|Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, Non-P.H.S.
endingPage	71
issn	1097-0142 0008-543X
issueIdentifier	1
pageRange	63-71
publicationName	Cancer
startingPage	63
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c9715a34c9ccde7ccc72cadee3277b94
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_801145fcc7f9b47c02742743f464d384 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ab80a732b5df33e85751c0a758afb577 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1c716aa20703a359417a51912fd4af7e http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_bf77bc192ee73548540b5c3852e027f4
bibliographicCitation	Araujo JC, Mathew P, Armstrong AJ, Braud EL, Posadas E, Lonberg M, Gallick GE, Trudel GC, Paliwal P, Agrawal S, Logothetis CJ. Dasatinib combined with docetaxel for castration-resistant prostate cancer: results from a phase 1-2 study. Cancer. 2012 Jan 01;118(1):63–71. PMID: 21976132; PMCID: PMC3898168.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_89190f4783b1544c2452dfae29ee4560 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9c9010ec6645d30290a71b3a99b1a241 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_54f2f722984440d22da83371ec97dc78 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66c48ad08eb8533d3a6a071f9f5bfad3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb81b28426184f135eb105d2d813bd8c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_82303ad91bf2ffe5db82da5eaae91f24 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_768a9c5a8f99258029528237e23b0cba http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_75c205c37f3efb5a34123e502e798968 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e05657a48f41f999befe8dc1c81cd7e1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bf1aeb911e5d7a9ced0051154dbe9fd3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_101a0629ea0466511ee9cf70657914b6
date	2011-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/21976132 https://doi.org/10.1002/cncr.26204 https://pubmed.ncbi.nlm.nih.gov/PMC3898168
isPartOf	https://portal.issn.org/resource/ISSN/1097-0142 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2771 https://portal.issn.org/resource/ISSN/0008-543X
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Dasatinib combined with docetaxel for castration-resistant prostate cancer: results from a phase 1-2 study
discusses	http://id.nlm.nih.gov/mesh/M0021333 http://id.nlm.nih.gov/mesh/M0184558 http://id.nlm.nih.gov/mesh/M0470497 http://id.nlm.nih.gov/mesh/M0026444 http://id.nlm.nih.gov/mesh/M0443608 http://id.nlm.nih.gov/mesh/M0018260
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D013844Q000008 http://id.nlm.nih.gov/mesh/D043823Q000008 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D011471Q000188 http://id.nlm.nih.gov/mesh/D011743Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D011743Q000493 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D020714 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000077143 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D013844Q000493 http://id.nlm.nih.gov/mesh/D043823Q000493 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D013844Q000009 http://id.nlm.nih.gov/mesh/D043823Q000009 http://id.nlm.nih.gov/mesh/D017430Q000378 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D001859Q000556 http://id.nlm.nih.gov/mesh/D002369 http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D000069439 http://id.nlm.nih.gov/mesh/D011743Q000009 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D001859Q000188
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3062316 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fce276cc0efd2412c7dafdbb1e82fcc8 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.21.77 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.1.3.1

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159660 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129879136

Total number of triples: 78.